Skip to main content
. 2022 Sep 30;66:85–88. doi: 10.1016/j.breast.2022.09.009

Table 2.

Best Response with CDK 4–6 inhibitors.

Response n %
Complete Remission (CR) 3 12
Partial Remission (PR) 12 48
Stable Disease (SD) 7 28
Progressive Disease 3 12
Objective Response Rate (CR + PR) 15 60
Disease Control Rate (CR + PR + SD) 22 88